About
Anti-Cancer Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalMiddle East
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
176
By Phase
PHASE2: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT03538951Lead Sponsor
Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
PHASE2Completed
83 participants
Started: May 23, 2018 · Completed: Dec 10, 2018
NCT02844777Lead Sponsor
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
PHASE2Completed
93 participants
Started: Jul 15, 2016 · Completed: May 26, 2017
Locations (1)
Headquarters
Ness Ziona, Israel
Map
Loading map...